Following Priority Review, the U.S. FDA granted HYRNUO® (sevabertinib) approval for the treatment of adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) ...
Currently there are sever global static variables that can make using libsrtp from multiple sub projects problematic. All non const variables should be removed. Current known ones include ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved Hernexeos for adults with unresectable or metastatic HER2-mutant NSCLC. It received accelerated ...
Community driven content discussing all aspects of software development from DevOps to design patterns. Packaged as part of the 2018 version 10 release, the Java var reserved word introduced type ...
Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes. HealthDay News — Men with nonmetastatic prostate cancer receiving ...
XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...
Dr Jonathan Goldman, of the University of California, Los Angeles, shares key updates in metastatic non-small cell lung cancer from ASCO 2025. Dr Goldman reviews findings from TROPION-Lung02, which ...
ABSTRACT: Security vulnerabilities are a widespread and costly aspect of software engineering. Although tools exist to detect these vulnerabilities, non-machine learning techniques are often rigid and ...
Subcutaneous pembrolizumab demonstrated comparable efficacy vs intravenous administration in non–small cell lung cancer, with a significantly shorter injection time. The subcutaneous (SC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results